Citation Impact
Citing Papers
PhysioBank, PhysioToolkit, and PhysioNet
2000 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations
2004
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Prognostic value of the VE/VCO slope calculated from different time intervals in patients with suspected heart failure
2006
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
1999
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Guillain-Barré syndrome
2016 Standout
Exercise Standards for Testing and Training
2013 Standout
Vitamin D Deficiency
2007 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
2017 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Prognostic Power of Ventilatory Responses During Submaximal Exercise in Patients With Chronic Heart Disease
2002
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes
1999
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial
2002
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy
2003
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
The odds of the three nons when an aptly prescribed medicine isn't working: non‐compliance, non‐absorption, non‐response
2002
Myocarditis
2011 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Cardiovascular Risk Reduction in High-Risk Pediatric Patients
2006
The impact of arrhythmias in acute heart failure
2004
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study
2001
Bone Loss and Turnover after Cardiac Transplantation1
1997
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Noninvasive assessment of transplant-associated arteriosclerosis
1998
Osteoporosis after solid organ and bone marrow transplantation
2003
Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction
2007
Autoantibodies against modified low-density lipoproteins in coronary artery disease
2003
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study
2001
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
2008
Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion
2006
High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry
1999
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
2004
Prevention of Osteoporosis in Heart Transplant Recipients: A Comparison of Calcitriol with Calcitonin and Pamidronate
2000
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Adherence to Medication
2005 Standout
Efficacy of Pamidronate for Osteoporosis in Patients with Cystic Fibrosis following Lung Transplantation
2000
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Inflammation as a Risk Factor for Atrial Fibrillation
2003 Standout
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Is oxidized low‐density lipoprotein present in vivo?
1998
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: A Comparison of Calcitriol, Vitamin D Plus Calcium, and Alendronate Plus Calcium
2003
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Protective Effect of Short-Term Calcitriol or Cyclical Etidronate on Bone Loss After Cardiac or Lung Transplantation
2001
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes
2001
Global Epidemiology of Campylobacter Infection
2015 Standout
Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor–Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E–Deficient Mice
2001
Evolution in functional complexity of heart rate dynamics: a measure of cardiac allograft adaptability
1998
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cardiac Remodeling in Response to 1 Year of Intensive Endurance Training
2014
The Metabolic Syndrome, Circulating Oxidized LDL, and Risk of Myocardial Infarction in Well-Functioning Elderly People in the Health, Aging, and Body Composition Cohort
2004
Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation
2001
Effect of Calcitriol on Bone Loss After Cardiac or Lung Transplantation
2000
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Noncalcemic Actions of Vitamin D Receptor Ligands
2005
Medication Adherence
2009 Standout
Bone metabolism and disease in chronic kidney disease
2003
Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease
2003
Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease
1998
Works of Johan Van Cleemput being referenced
Role of alfacalcidiol on bone quality and immunomodulation in autoimmune disease and organ transplantation
1997
PREVENTION OF BONE LOSS IN CARDIAC TRANSPLANT RECIPIENTS
1996
Effect of late medication non-compliance on outcome after heart transplantation: A 5-year follow-up
2004
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
2013
Heart Rate Variability After Cardiac Transplantation in Humans
1996
Peak Oxygen Uptake Better Predicts Outcome Than Submaximal Respiratory Data in Heart Transplant Candidates
2000
Oxidized Low Density Lipoprotein Is a Prognostic Marker of Transplant-Associated Coronary Artery Disease
2000
Timing and quantification of bone loss in cardiac transplant recipients
1995
Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients
1997
Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients.
1998
Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease
1998
Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol
2000
Survival and heart failure therapy in chronic dialysis patients with heart failure and reduced left ventricular ejection fraction: an observational retrospective study.
2013
Myocarditis Associated With Campylobacter Enteritis: Report of Three Cases
2012
Timing and quantification of bone loss in cardiac transplant recipients
1995
Cardiac MRI
2012
Dobutamine stress echocardiography after heart transplantation.
1995